As a Clinical Scientist – ICOS, you will lead the clinical development of novel, first-in-class compounds, providing leadership on clinical and strategic issues that impact the success of our Medicine Development units.
This role will give YOU the opportunity to lead key activities to progress YOUR career, these responsibilities include some of the following…
- Clinical-strategy leadership for GSK development assets Core Team
- Design and execution (Back-up Medical Monitor) for multiple-phase studies
- Strategic leadership for the clinical development of GSK assets
- Medical Monitoring, design and execution of studies in healthy volunteers
- Leadership of the clinical matrix teams for assigned assets
The Clinical Scientist has accountability for strategy, design and interpretation of study results that provide data to adequately address questions concerning efficacy/effectiveness, safety, applicability to targeted patient population, and clinical and commercial value that are consistent with the compounds’ phase of development while ensuring that patient safety is of paramount concern and that regulatory requirements are incorporated through:
- Leadership of the clinical study teams in the design, development and interpretation of results of high quality studies
- Effectively interfaces with and influences across a diverse and scientifically advanced community of internal and external experts, including collaborations with regulators, payors, consultants, investigators and medical affairs (Including GMAL) and commercial staff to deliver clinical programs aligned to business strategy.
- Accountability for supporting medical governance (through the Medical Monitor/Physician Project Lead (PPL) and other Study Team members/stakeholders, as appropriate) and regulatory reporting at the study level by providing leadership at study level to assure overall safety of the study subjects
Further to study/project leadership accountability, the Clinical Scientist may manage other staff within Clinical Sciences.
The Clinical Scientist – ICOS is expected but not limited to:
- Ensure delivery of quality study strategy and design, understand the analysis and interpretation of data throughout the study
- Lead or Contribute as appropriate to the end to end (protocol concept to final study report) delivery of clinical development activities which ensure consistency with the clinical development strategy for regulatory approvals, reimbursable medicines, and successful lifecycle management; demonstrate ability to incorporate global considerations into strategic and operational decisions.
- Understand the asset’s biological mechanism, clinical strategy, scientific interpretation of disease and target-based literature
- Integrate data from internal, and external academic, conference and competitor sources
- Understand and support creation and support of competitor landscape, medical need, regulatory strategy
- Appropriately interact with Key External Experts (KEEs), Key Opinion Leaders (KOLs), collaborators, advisory boards, etc.
- Implement new business processes and strategies and may also proactively identify issues and propose strategies to manage implications and risks on clinical study/Clinical Development plan (CDP)
- Ensure the high quality of protocol documents are developed aligned to the CDP to effectively determine a medicine’s potential efficacy, safety profile, key areas of product differentiation and value to patient in the shortest possible timeframe
- Drive/contribute to clinical components of the IB, and documents for regulatory submissions and advisory requirement, including scientific advice, IND, EoP2, pre-NDA/BLA meetings, NDA/BLA and MAA documents
- Develop studies in accordance with current GSK policies and procedures
- As appropriate, Lead Clinical Matrix Teams
- Accountable for Phase 1-4 study design and P1 clinical pharmacology study design supporting the CDP
- Understands objectives; safety, efficacy, statistical endpoints; epidemiological and operational elements; the biology, pharmacology and toxicology; data driven phenotypes identification, biomarkers, microbiology, virology
- Authors the Clinical Study Proposal (CSP), prepares and presents the study at Protocol Review Forum (PRF), incorporates any changes suggested post-governance meetings
- Ensures study protocol reflects input from internal and/or external experts/thought leaders
- Liaises with all functions as appropriate to ensure study evaluates key aspects of the Asset Product Profile critical to product differentiation/reimbursement where possible
- Provides input into and reviews other relevant study documents including but not limited to, the informed consent (ICF), protocol deviation management plan (PDMP), study reference manual (SRM)
- Contributes to all regulatory reporting requirements (e.g., DSUR, INDSRs, etc.)
- Ensures prompt, quality responses to Institutional Review Boards (IRB)/Ethics Review Committees (ERC), Independent Data Monitoring Committees (IDMC), etc.
- If Internal Safety Review Committee (ISRC)/IDMC data review is required, participates in, or leads identification of internal or external ISRC/IDMC members, respectively and preparation of charter. Co-ordinates with Medical Monitor/PPL and other Study Team members and stakeholders.
- Identifies and ensures the review of critical safety datasets for in-stream data review in line with Medical Governance objectives (through Medical Monitor/PPL and other stakeholders, as appropriate)
- Participates in eCRF development and may participate in UAT
- Reviews the reporting and analysis plan (RAP) and advises on required outputs
- Participates in data review ongoing through study including interim analyses, in-stream data review, etc.
- Responsible for ensuring the Go/No-Go criteria have been set for the study
- Presents the scientific rationale and study design at Investigator Meetings and responds to scientific questions arising from sites during study conduct
- Ensures prompt, quality communications with sites regarding protocol clarification and procedural queries
- Ensures completion of medical governance (through a physician on the team) and regulatory reporting at the start to ensure overall safety of the study subjects
- Interpretation of study data and scientific content of clinical study reports (CSRs) and regulatory submissions
- Ensures CSR and other documents reflect input from internal and/or external experts/thought leaders as appropriate
- Understands and anticipates questions from internal and/or external stakeholders regarding data results
- Working with the PPL and other stakeholders, clearly communicates results to internal and external stakeholders and regulators
- Drives content of other clinical documents (e.g. Investigator Brochure); regulatory documents input (e.g. DSURs, BRMP, DCSI, Annual Safety Reports, PBRs, etc.)
- Knowledge of regulatory requirements to support registration; generates processes/plans and/or provides clinical input into briefing documents to support regulatory interactions/approvals and active attendance at IND, EoP2, scientific advice, pre-NDA/BLA, NDA/MAA, AdCom meetings
- Leads completion/filing of key components of clinical modules (NDA/BLA/MAA, AdCom prep, Scientific Advice) for marketing authorization
- Prepares and presents data externally in the form of abstracts, posters, presentations for symposia and conferences and external journal publications
- Inputs into the organisation of Advisory boards and other scientific engagement activities.
- Delivers of end-of-study reports and publication/presentation of results
- Reviews/evaluates external collaborations (e.g. SCS, ISS)
We are looking for professionals with these required skills to achieve our goals:
- Basic Life Science degree or equivalent and 5+ years of industry or relevant clinical experience
- Robust knowledge of disease-specific research priorities, public health needs, competitor landscape, clinical practice trends and treatment guidelines evolution
- Broad understanding of the pharmaceutical industry and the clinical development process
- Clinical training and/or applicable clinical research experience; understanding of running clinical trial from concept study idea to publication
- Matrix management experience; ability to establish and build internal and external relationships at all levels in a highly dynamic and matrixed environment
- Highly developed communication skills appropriate to the target audience, promoting effective decision-making where necessary
- Good interpersonal relationship building/maintenance
If you have the following characteristics, it would be a plus:
- Advanced degree (e.g. MS, PhD, PharmD) or equivalent experience
- Oncology or immuno-oncology experience
- Excellent leadership and influencing skills
- Experience taking strong cross functional leadership role in clinical development; experience & understanding of clinical development from early stage through to regulatory submission and market support.
- Advanced understanding of clinical development and/or marketed support to recommend, influence, and implement improvements to processes.
- Understands the study, project, and program level and can function successfully across a variety of projects.
- Understands the impact of decisions and maintains awareness of business drivers and alternative solutions for project delivery.
- Demonstrates a thorough knowledge of worldwide regulatory and safety requirements as pertains to drug development, research projects, and/or market support.
- Demonstrated experience leading in both matrix and line environment to deliver projects, and manage change
- Ability to establish and build internal and external relationships at all levels in a highly dynamic and matrixed environment.
Today there are still millions of people without access to basic healthcare, thousands of diseases without adequate treatments and millions more people who suffer from everyday ailments. At GSK we want to change this.
As a global healthcare company, we take on some of the world’s biggest healthcare challenges. By delivering a sustainable business, we provide health benefits to patients and consumers, improved shareholder returns as well as supporting wider society. We have three world-leading businesses that research, develop and manufacture innovative pharmaceutical medicines, vaccines and consumer healthcare products.
We are committed to widening access to our products, so more people can benefit, no matter where they live in the world or what they can afford to pay. Each of our three businesses benefits from GSK’s commercial infrastructure, integrated supply networks and significant global presence.
As a global company, our reward packages are designed to meet the needs of our geographically diverse workforce. They are benchmarked against industry standards and relevant to your job, no matter where you live.
Our reward package includes:
- A competitive base salary
- An annual bonus that rewards you for your individual contribution to our strategy, as well as business targets
- Benefit programs designed to support you and your family, including access to healthcare and well-being programs, pension plan membership, savings programs, time off and childcare support
- Employee recognition programs which reward exceptional achievements
- Share ownership schemes which link your reward to GSK’s longer term performance
- A performance and development program that helps you identify what you need to do, and the behaviors you need to demonstrate, to achieve success.